Rob Rodrigues

Partner

Bio

Rob Rodrigues is a seasoned litigator specializing in high-stakes business and intellectual property disputes in Brazil. Renowned for his strategic acumen, Rob delivers unmatched expertise to FORTUNE 500 companies and dynamic startups alike. He expertly navigates complex legal landscapes, ensuring robust patent portfolio management for top-tier life sciences and telecommunications firms. His deep market insight positions him as a first-choice advisor for both acquisition and enforcement actions.

Rob's excellence has been recognized by a number of leading publications. In 2024, Lexology listed him as a Legal Influencer in Dispute Resolution. Chambers describes Rob as a "superb litigator", "a very competent professional", and "outstanding in providing business-oriented advice." Who's Who Legal praises "his top-tier practice advising clients on life sciences-related patent litigation." The Legal 500 reports that clients describe Rob as someone "who stands out for his strong background in both the IP area, both in terms of litigation and in relation to more technical topics." Client testimonials in IAM Strategy 300 laud him for his "deep understanding of IP issues and keen strategic insight, which he leverages to add value and monetise portfolios."

Throughout his career, Rob has spearheaded multiple preliminary injunction proceedings and trials for global companies in Brazil. He also facilitates monumental IP asset transactions, with a keen eye on managing risks.

A Stanford Law School LL.M. alumnus, Rob served as a lead editor of the Stanford Technology Law Review. He has contributed extensively to global technology law journals and currently holds an editorial role at the Kluwer IP Blog.

Education

- LL.M. in Law, Science and Technology, from Stanford Law School.

- Residential Scholarship at Hoover IP Institute on the Economics and Politics of Innovation.

- J.D. from Universidade Federal do Rio de Janeiro (UFRJ).

Languages

Portuguese, English, Spanish

Publications

News
News

Brazilian Patent office publishes roadmap proposal of IP Law reform

Brazil's patent office proposes IP law reforms to speed prosecution, modernize procedures and address patents, AI, designs, trademarks and biotech.
2026
10
min read
Life Sciences & Health
Life Sciences & Health

Debunking Biopharmaceutical Patent Myths: An Evidence-Based Analysis

Evidence-based analysis shows biopharmaceutical patents are not excessive, do not create thickets, and can support timely generic competition and real innovation.
2026
18
min read
Rob Rodrigues
Lisa Mueller, Julie M. Lake, Mira A. Mulvaney, Richard F. Kurz, Wan Chieh (Jenny) Lee, Gustavo de Freitas Morais
Life Sciences & Health
Life Sciences & Health

Brazil: Anvisa updates its position on biosimilar interchangeability

Anvisa’s new note supports biosimilar interchangeability in Brazil, aligning with global practice and reinforcing safeguards for switching and traceability.
2026
10
min read
Patent Litigation & Enforcement
Patent Litigation & Enforcement

Webcast | Brazil Patent Landscape

Rob Rodrigues surveys Brazil’s patent enforcement landscape, highlighting rapid preliminary injunctions and their impact on multinational patent strategy.
2026
1
min read
Life Sciences & Health
Life Sciences & Health

Brazil Tightens the Screws on Technology Transfer Pricing in Productive Development Partnerships: What the Ministry of Health's New Methodology Means for IP Holders

Brazil's Ministry of Health issued a new methodology for valuing technology transfer in PDPs, establishing pricing benchmarks and reimbursement rules for IP.
2026
8
min read